Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

ZYPADHERA 405 mg, powder and solvent for prolonged release suspension for injection

Active Ingredient:
olanzapine pamoate monohydrate
Company:  
Eli Lilly and Company Limited See contact details
ATC code: 
N05AH03
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) User Manual Risk Materials Live Chat HCP Med Info
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

ZYPADHERA 210 mg, 300 mg, and 405 mg, powder and solvent for prolonged release suspension for injection Patient Alert Card

ZYPADHERA 210 mg, 300 mg, and 405 mg, powder and solvent for prolonged release suspension for injection Patient Alert Card containing important safety information for patients.

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Eli Lilly and Company Limited
Company image
Address
Lilly House, Basing View, Basingstoke, Hampshire, RG21 4FA
WWW
https://www.lilly.com/uk/
Telephone
+44 (0)1256 315 000
Medical Information e-mail
[email protected]
Medical Information Website
https://www.lillymedical.co.uk/en-gb